Home » Health » -title Argentina Develops Early Colon Cancer Detection Kit

-title Argentina Develops Early Colon Cancer Detection Kit

by Dr. Michael Lee – Health Editor

summary of the InTest.Ar‍ Colorectal Cancer Self-Test:

Here’s a breakdown of ⁣the key facts⁣ about InTest.Ar and⁤ their colorectal cancer self-test, based​ on the provided text:

what it is:

* A home-based⁤ self-test for early detection of colorectal cancer.
* More ​precise and specific than a traditional stool test.
* ‌ Up⁢ to 20 times cheaper than ‍a colonoscopy.
* ⁣ Requires no prior readiness.

How it works:

* Analyzes molecular ⁢information.
* Utilizes artificial intelligence (machine learning) to integrate molecular data with anonymous clinical data (age, risk factors, occult blood results) for improved ​diagnostic ⁢accuracy.
* Will incorporate incremental learning ⁤to improve models as new data becomes available.

Current Status & Next⁢ Steps:

* optimization: Currently focused on optimizing the​ test’s sensitivity ‌and specificity.
* Pilot Testing: Articulating collaborations with⁢ hospitals ‌and research centers for pilot tests with patient​ samples.
* Regulatory Approval: ⁣will⁢ begin the​ registration process with ANMAT (Argentina‘s regulatory body for food and medical ⁣technology).
* ⁣ Production: Plans to ⁤manufacture the kit ​locally⁢ in Argentina, partnering with companies experienced in molecular biology input​ production.

Benefits:

*​ ​ Increased Screening Rates: ‍Aims to ‍increase ⁢participation​ in‌ colorectal cancer screening by making ⁢it⁤ more convenient and accessible.
* ⁢ Improved Mortality Rates: ‌ Early detection can ⁢reduce ​mortality by up ​to 90%.
* ‌ Resource Optimization: Helps doctors‌ identify patients ⁣who truly ⁣need a colonoscopy, optimizing‍ healthcare resources.
*‍ ⁤ Cost-Effective: ​ Significantly cheaper than a ‌colonoscopy.

Market & Distribution:

* Will be ⁤available ⁣in Argentina under medical ⁣prescription.
*‍ ‍ Plans to pursue agreements with social, prepaid,‌ and public health systems for inclusion⁢ in​ mandatory prevention ⁢studies.
* ​Aims‍ to expand to the regional market.

Background:

* The team includes specialists in biotechnology, ⁢molecular ⁤biology, public health, ‍and bioinformatics.
*⁣ ⁣Was a‌ finalist for the Balseiro Institute’s IB50K⁢ award, which‌ helped structure their ‌business model.

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.